Compare MEDP & HST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | MEDP | HST |
|---|---|---|
| Founded | 1992 | 1927 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Commercial Physical & Biological Resarch | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 12.9B | 13.1B |
| IPO Year | 2016 | 1998 |
| Metric | MEDP | HST |
|---|---|---|
| Price | $480.16 | $19.15 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 13 | 15 |
| Target Price | ★ $498.25 | $19.23 |
| AVG Volume (30 Days) | 257.9K | ★ 7.8M |
| Earning Date | 04-22-2026 | 05-06-2026 |
| Dividend Yield | N/A | ★ 5.01% |
| EPS Growth | ★ 20.98 | 11.11 |
| EPS | ★ 15.28 | 1.10 |
| Revenue | N/A | ★ $5,387,000,000.00 |
| Revenue This Year | $13.15 | N/A |
| Revenue Next Year | $7.47 | $1.28 |
| P/E Ratio | $30.11 | ★ $17.24 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $250.05 | $12.27 |
| 52 Week High | $628.92 | $21.00 |
| Indicator | MEDP | HST |
|---|---|---|
| Relative Strength Index (RSI) | 55.95 | 50.20 |
| Support Level | $452.55 | $16.99 |
| Resistance Level | $501.30 | $19.30 |
| Average True Range (ATR) | 16.15 | 0.44 |
| MACD | 4.20 | 0.01 |
| Stochastic Oscillator | 97.26 | 49.51 |
Medpace is a late-stage contract research organization that provides full-service drug-development and clinical trial services to small and midsize biotechnology, pharmaceutical, and medical device firms. It also offers ancillary services, including bioanalytical laboratory services and imaging capabilities. The company was founded over 30 years ago and has more than 5,400 employees across 40 countries. Medpace is headquartered in Cincinnati, Ohio, and its operations are primarily based in the US, with additional presence in Europe, Asia, South America, Africa, and Australia. Cinven, a global private equity firm, acquired Medpace for $915 million in 2014 and exited its investment in 2018.
Host Hotels & Resorts owns 80 predominantly urban and resort upper-upscale and luxury hotel properties representing nearly 43,000 rooms, mainly in the United States. Host recently sold off the company's interests in a joint venture owning a portfolio of hotels throughout Europe and also sold other joint ventures that owned properties in Asia and the United States. The majority of Host's portfolio operates under the Marriott and Starwood brands.